ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Louisiana » Gastroenterology

Top Gastroenterology Prescribers in Louisiana

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
CLIFFORD TILLMAN

Gastroenterology

7,620

$488K

814
607 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

9%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 38%

$64
Average prescription price

Avg: $147

LUIS ALVAREZ M.D.

Gastroenterology

4,702

$634K

1010
602 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

47%
prescriptions for brand name drugs

Avg: 38%

$135
Average prescription price

Avg: $147

WILFORD STOKES M.D.

Gastroenterology

4,365

$403K

648
480 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 38%

$92
Average prescription price

Avg: $147

PASAM RAO MD

Gastroenterology

3,094

$288K

489
277 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

44%
prescriptions for brand name drugs

Avg: 38%

$93
Average prescription price

Avg: $147

MARC FRIEDMAN MD

Gastroenterology

2,940

$194K

263
235 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 38%

$66
Average prescription price

Avg: $147

STEPHEN ABSHIRE MD

Gastroenterology

2,922

$281K

543
441 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 38%

$96
Average prescription price

Avg: $147

HALINA POLEK-NOWAKOWSKA MD

Gastroenterology

2,771

$447K

586
440 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 38%

$161
Average prescription price

Avg: $147

JAMES SMITH MD

Gastroenterology

2,662

$277K

1533
1210 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

72%
prescriptions for brand name drugs

Avg: 38%

$104
Average prescription price

Avg: $147

BENTON OUBRE

Gastroenterology

2,605

$224K

447
344 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 38%

$86
Average prescription price

Avg: $147

DAVID SILVERS MD

Gastroenterology

2,540

$340K

446
360 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 38%

$134
Average prescription price

Avg: $147

GEORGE PUENTE M.D.

Gastroenterology

2,493

$253K

629
535 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 38%

$102
Average prescription price

Avg: $147

DAVID DIES M.D

Gastroenterology

2,475

$1M

474
324 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 38%

$405
Average prescription price

Avg: $147

CHARLES MONIER MD

Gastroenterology

2,314

$213K

568
471 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

43%
prescriptions for brand name drugs

Avg: 38%

$92
Average prescription price

Avg: $147

STEPHEN PERSON M.D.

Gastroenterology

2,225

$232K

388
312 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 38%

$104
Average prescription price

Avg: $147

CLAYTON COON M.D.

Gastroenterology

2,218

$217K

554
455 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

42%
prescriptions for brand name drugs

Avg: 38%

$98
Average prescription price

Avg: $147

GLENN HEDGPETH MD

Gastroenterology

2,078

$141K

127
24 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

31%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 38%

$68
Average prescription price

Avg: $147

VERONICA DUGAN M.D.

Gastroenterology

2,065

$256K

417
282 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 38%

$124
Average prescription price

Avg: $147

WILLIAM ANDERSON M.D.

Gastroenterology

2,058

$306K

545
441 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

40%
prescriptions for brand name drugs

Avg: 38%

$149
Average prescription price

Avg: $147

RONALD LEO M.D.

Gastroenterology

2,007

$227K

390
316 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 38%

$113
Average prescription price

Avg: $147

SHABAN FARUQUI M.D.

Gastroenterology

2,004

$555K

457
282 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 38%

$277
Average prescription price

Avg: $147

HOWARD BRENNER M.D.

Gastroenterology

2,004

$267K

505
387 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

34%
prescriptions for brand name drugs

Avg: 38%

$133
Average prescription price

Avg: $147

DASARATHY SRINIVAS M.D.

Gastroenterology

1,991

$408K

374
285 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 38%

$205
Average prescription price

Avg: $147

KHALID MOUSSA MD

Gastroenterology

1,986

$992K

325
179 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

47%
prescriptions for brand name drugs

Avg: 38%

$500
Average prescription price

Avg: $147

ARTHUR POCH M.D.

Gastroenterology

1,983

$229K

486
402 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 38%

$116
Average prescription price

Avg: $147

RIAN TANENBAUM M.D.

Gastroenterology

1,962

$272K

601
480 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

47%
prescriptions for brand name drugs

Avg: 38%

$138
Average prescription price

Avg: $147

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank